Research programme: hepcidin peptide mimetics - Merganser Biotech / University of California at Los Angeles

Drug Profile

Research programme: hepcidin peptide mimetics - Merganser Biotech / University of California at Los Angeles

Alternative Names: Hepcidin mimetic peptides; M 009; Minihepcidin peptides; Minihepcidins

Latest Information Update: 21 Feb 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of California at Los Angeles
  • Developer Merganser Biotech; University of California at Los Angeles; Weill Cornell Medical College
  • Class Peptides
  • Mechanism of Action Hepcidin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Beta-thalassaemia; Haemochromatosis; Iron overload; Polycythaemia vera

Most Recent Events

  • 20 Feb 2015 Preclinical trials in Beta-thalassaemia in USA (Parenteral)
  • 20 Feb 2015 Preclinical trials in Haemochromatosis in USA (Parenteral)
  • 20 Feb 2015 Preclinical trials in Iron overload in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top